The pharmaceutical giant, AstraZeneca, has announced that it is ready to provide the market with a possible vaccine to treat the Corona virus, starting next September.
The company said it had contracts to produce at least 400 million doses of the vaccine, which it is developing in cooperation with the University of Oxford. According to the BBC, "BBC".
AstraZeneca said it was able to produce 1 billion doses of "AZD1222" vaccine during this year and the following year.
Initial trials and tests for this vaccine are continuing, and AstraZeneca said it is aware that the vaccine may not achieve the desired results.
But the company added that it is committed to developing the program for clinical use (in hospitals and clinics), and not within the confines of laboratory trials.
The company indicated that it obtained more than $ 1 billion in support from the US Department of Health's Biomedical Research and Development Authority (BARDA) to develop, produce, and deliver the vaccine

Follow our latest local and sports news and the latest political and economic developments via Google news